Skip to main navigation menu Skip to main content Skip to site footer
##common.pageHeaderLogo.altText##

Articles

Vol. 2 No. 1 (2011): January – March 2011

Discovery of Novel Inhibitors Against Resistant Streptococcus pneumoniae MurF Enzyme using Phamracophore Modeling and QSAR Analysis

DOI
https://doi.org/10.37285/ijddd.2.1.7
Submitted
November 28, 2024
Published
2024-12-08

Abstract

Main aim of the current study was to discover novel inhibitors against Streptococcus pneumoniae MurF enzyme using analogue based drug design. Pharmacophore mapping and 3D-QSAR analysis was performed on some previously synthesized and evaluated sulfonamide derivatives which are known to be potent inhibitors of penicillin resistant Streptococcus pneumoniae MurF receptor. 3D-QSAR study based on the principle of alignment of pharmacophoric features was performed on the same set of inhibitors using the PHASE module of Schrodinger suite. A five point pharmacophore, ADHRR, with one hydrogen bond acceptor, one hydrogen bond donor, one hydrophobic group and two aromatic rings yielded a statistically significant 3D-QSAR model with 0.96 as R2 value for three PLS components and good predictive correlation coefficients of Q2 = 0.8084, F = 140.6 and Pearson-R = 0.9157 for the test set with nine compounds. Thus, indicating good predictive power of the pharmacophore based 3D-QSAR model.

References

  1. [1] http://www.whoindia.org/en/section6/section453.htm
  2. [2] Longenecker KL.; Stamper GF.; Hajduk PJ.; Fry EH.; Jakob CG.; Harlan JE.; Edalji R.; Bartley DM.; Walter KA.; Solomon LR.; Holzman TF.; Gu YG.; Lerner CG.; Beutel BA.; Stoll VS. Protein sci. 2005, 14, 3039.
  3. [3] http://textbookofbacteriology.net/resantimicrobial.html
  4. [4] El Zoeiby A.; Sanschagrin, F.; Levesque, R.C. FEMS Microbiol. Lett. 2001, 201, 229.
  5. [5] Wong, K.K.; Pompiano, D.L. In Rosen, B.P.; Mobashery, S., Eds.; Plenum: NY, 1998, 197.
  6. [6] Goldman, R.C.; Branson, A. Curr. Pharm. Design. 1999, 5, 473.
  7. [7] Santosh A. Khedkar.; Alpeshkumar K. Malde and Evans C. Coutinho. J. chem.. Inf. Model. 2007, 47, 1839.
  8. [8] Miller, D. J.; Hammond, S. M.; Anderluzzi, D.; Bugg, T. D. J. Chem. Soc., Perkin Trans 1 1998, 1, 131.
  9. [9] Bertrand, J. A.; Auger, G.; Martin, L.; Fanchon, E.; Blanot, D.; Le Beller, D.; van Heijenoort, J.; Dideberg, O.J. Mol. Biol. 1999, 289, 579.
  10. [10] Jorgensen, W. L. Science 2004, 303, 1813.
  11. [11] Bembenek, S. D.; Keith, J. M.; Letavic, M. A.; Apodaca, R.; Barbier,A. J.; Dvorak, L.; Aluisio, L.; Miller, K. L.; Lovenberg, T. W.; Carruthers, N. Bioorg.Med. Chem. 2008, 16, 2968.
  12. [12] http://www.schrodinger.com
  13. [13] Mutasem O. Taha.; Naji Atallah.; Amal G. Al-Bakri.; Catherine Paradis-Bleau.; Hiba Zalloum.; Khaled S. Younis.; Roger C. Levesque. Bioorg. Med. Chem. 2008, 16, 1218.
  14. [14] Yu Gui Gu.; Alan S. Florjancic.; Richard F. Clark.; Tianyuan Zhang.; Curt S. Cooper.; David D. Anderson.; Claude G. Lerner.; J. Owen McCall.; Yingna Cai,; Candace L. Black-Schaefer.; Geoffrey F. Stamper.; Philip J. Hajduk and Bruce A. Beutel. Bioorg. Med. Chem. Lett. 2004, 14, 267.
  15. [15] Samo Turk.; Andreja Kovac.; Audrey Boniface.; Julieanne M. Bostock.; Ian Chopra.; Didier Blanot.; Stanislav Gobec. Bioorg. Med. Chem. 2009, 17, 1884.
  16. [16] Matej Sova.; Andreja Kovac.; Samo Turk.; Martina Hrast.; Didier Blanot.; Stanislav Gobec. Bioorg. Chem.2009, 37, 217.